138 related articles for article (PubMed ID: 17573897)
21. Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway.
Gamero AM; Larner AC
J Biol Chem; 2001 Apr; 276(17):13547-53. PubMed ID: 11278370
[TBL] [Abstract][Full Text] [Related]
22. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
23. A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.
Guo CJ; Yang LS; Zhang YF; Wu YY; Weng SP; Yu XQ; He JG
PLoS One; 2012; 7(7):e41092. PubMed ID: 22844427
[TBL] [Abstract][Full Text] [Related]
24. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
25. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
[TBL] [Abstract][Full Text] [Related]
26. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
Yin Y; Romero N; Favoreel HW
J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
[TBL] [Abstract][Full Text] [Related]
27. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction.
Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H
Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647
[TBL] [Abstract][Full Text] [Related]
28. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K
Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712
[TBL] [Abstract][Full Text] [Related]
29. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis delta virus inhibits alpha interferon signaling.
Pugnale P; Pazienza V; Guilloux K; Negro F
Hepatology; 2009 Feb; 49(2):398-406. PubMed ID: 19085955
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
32. Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm.
D'Cruz OJ; Vassilev AO; Uckun FM
Fertil Steril; 2001 Aug; 76(2):258-66. PubMed ID: 11476770
[TBL] [Abstract][Full Text] [Related]
33. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α.
Tomita S; Ishibashi K; Hashimoto K; Sugino T; Yanagida T; Kushida N; Shishido K; Aikawa K; Sato Y; Suzutani T; Yamaguchi O
Cancer Sci; 2011 Jan; 102(1):57-63. PubMed ID: 21054677
[TBL] [Abstract][Full Text] [Related]
34. Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation.
Dinwiddie DL; Harrod KS
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):661-70. PubMed ID: 18218993
[TBL] [Abstract][Full Text] [Related]
35. [Effect of HCV NS5A on STAT1 phosphorylation and nuclear translocation induced by IFN alpha-2b].
Cao J; Zhou Y; Gong GZ
Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):894-7. PubMed ID: 17196131
[TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
[TBL] [Abstract][Full Text] [Related]
37. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
38. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
Martin del Campo SE; Levine KM; Mundy-Bosse BL; Grignol VP; Fairchild ET; Campbell AR; Trikha P; Mace TA; Paul BK; Jaime-Ramirez AC; Markowitz J; Kondadasula SV; Guenterberg KD; McClory S; Karpa VI; Pan X; Olencki TE; Monk JP; Mortazavi A; Tridandapani S; Lesinski GB; Byrd JC; Caligiuri MA; Shah MH; Carson WE
J Immunol; 2015 Sep; 195(5):1995-2005. PubMed ID: 26238487
[TBL] [Abstract][Full Text] [Related]
39. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
Poat B; Hazari S; Chandra PK; Gunduz F; Balart LA; Alvarez X; Dash S
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20949125
[TBL] [Abstract][Full Text] [Related]
40. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
